258 related articles for article (PubMed ID: 1323814)
21. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.
Lee JS; Scott C; Komaki R; Fossella FV; Dundas GS; McDonald S; Byhardt RW; Curran WJ
J Clin Oncol; 1996 Apr; 14(4):1055-64. PubMed ID: 8648357
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients.
Correale P; Botta C; Basile A; Pagliuchi M; Licchetta A; Martellucci I; Bestoso E; Apollinari S; Addeo R; Misso G; Romano O; Abbruzzese A; Lamberti M; Luzzi L; Gotti G; Rotundo MS; Caraglia M; Tagliaferri P
Cancer Biol Ther; 2011 Jul; 12(2):112-8. PubMed ID: 21525780
[TBL] [Abstract][Full Text] [Related]
23. Clinical studies of irinotecan alone and in combination with cisplatin.
Fukuoka M; Masuda N
Cancer Chemother Pharmacol; 1994; 34 Suppl():S105-11. PubMed ID: 8070018
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of high-dose etoposide combined with cisplatin for treating relapsed small cell lung cancer.
Masuda N; Fukuoka M; Matsui K; Negoro S; Takada M; Sakai N; Ryu S; Takifuji N; Ito K; Kudoh S
Cancer; 1990 Jun; 65(12):2635-40. PubMed ID: 1692757
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
[TBL] [Abstract][Full Text] [Related]
26. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
Bonomi P; Faber LP; Recine D; Lincoln S
Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927
[TBL] [Abstract][Full Text] [Related]
27. A multicenter phase II trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer.
Splinter T; Kok T; Kho S; Lameris H; ten Kate F; Dalesio O; Dolman B; Palmen F; Bouvy J; Burghouts J
Semin Oncol; 1986 Sep; 13(3 Suppl 3):97-103. PubMed ID: 3020707
[TBL] [Abstract][Full Text] [Related]
28. Platinum/etoposide therapy in non-small cell lung cancer.
Bonomi P
Oncology; 1992; 49 Suppl 1():43-50. PubMed ID: 1323811
[TBL] [Abstract][Full Text] [Related]
29. Treatment of advanced non-small cell lung cancer (NSCLC): the "Umbria" cooperative study.
Crinó L; Darwish S; Corgna E; Meacci ML; Di Costanzo F; Buzzi F; Fornari G; Santi F; Ballatori E; Luccioli L
Semin Oncol; 1988 Dec; 15(6 Suppl 7):52-5. PubMed ID: 2851180
[TBL] [Abstract][Full Text] [Related]
30. Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study.
Muscato JJ; Cirrincione C; Clamon G; Perry MC; Omura G; Berkowitz I; Reid T; Herndon JE; Green MR
Lung Cancer; 1995 Dec; 13(3):285-94. PubMed ID: 8719068
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
Klastersky J; Sculier JP; Dabouis G; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R
Semin Oncol; 1990 Feb; 17(1 Suppl 2):20-4. PubMed ID: 2154855
[TBL] [Abstract][Full Text] [Related]
32. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L
J Infus Chemother; 1996; 6(1):43-6. PubMed ID: 8748007
[TBL] [Abstract][Full Text] [Related]
33. High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma.
Yang CH; Cheng AL; Yeh KH; Yu CJ; Lin JF; Yang PC
Cancer; 1999 Aug; 86(3):415-20. PubMed ID: 10430249
[TBL] [Abstract][Full Text] [Related]
34. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
[TBL] [Abstract][Full Text] [Related]
37. Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.
Gridelli C; Rossi A; Scognamiglio F; Guida C; Fiore F; Gatani T; Scoppa G; Pergola M
Anticancer Res; 1997; 17(6D):4755-8. PubMed ID: 9494602
[TBL] [Abstract][Full Text] [Related]
38. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD; Hong WK
J Clin Oncol; 2001 May; 19(10):2626-37. PubMed ID: 11352954
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
Shepherd FA; Goss PE; Latreille J; Stewart D; Logan D; Evans WK; Maroun J; Warner E
Semin Oncol; 1990 Apr; 17(2 Suppl 4):19-23. PubMed ID: 2159185
[TBL] [Abstract][Full Text] [Related]
40. [Prolonged oral etoposide therapy in advanced stage lung cancer].
Bozóky G; Ruby E; Góhér I; Mohos A; Lengyel M
Orv Hetil; 1997 Jul; 138(28):1791-5. PubMed ID: 9280873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
